NCT00253552: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders |
|
|
| Terminated | N/A | 4 | US | filgrastim, busulfan, cyclophosphamide, cyclosporine, etoposide, methotrexate, allogeneic bone marrow transplantation, radiation therapy | OHSU Knight Cancer Institute, National Cancer Institute (NCI) | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Sarcoma | 05/06 | 05/06 | | |
NCT00594308: In-Vivo Activated T-Cell Depletion to Prevent GVHD |
|
|
| Terminated | N/A | 10 | US | Cyclophosphamide, Fludarabine, Cyclosporine, Mycophenolate mofetil, Basiliximab | Indiana University | Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Myelodysplasia, Lymphoma, Non-Hodgkin's, Mantle-Cell Lymphoma, Hodgkin's Disease, Multiple Myeloma, Myelofibrosis | 10/08 | | | |
